Submodule
Definition, Staging, and Phenotype
Heart failure is a clinical syndrome with objective cardiac support. Stage describes disease progression, while ejection fraction describes current or historical ventricular behavior.
- Clinical syndrome
- Stages A through D
- Ejection-fraction phenotypes
- Limits of ejection fraction
Prevent injury
Find structure or biomarkers
Treat disease and syndrome
Refer before the window closes
Require clinical and objective evidence
Dyspnea, fatigue, edema, orthopnea, and exercise intolerance are important but nonspecific. Structural or functional cardiac abnormality plus elevated filling pressures, natriuretic peptides, imaging, or objective congestion supports the syndrome. Pulmonary, renal, hepatic, venous, hematologic, and deconditioning mimics remain active alternatives.
Use stages to record progression
Stage A identifies risk without structural disease or symptoms. Stage B identifies pre-heart failure through structure, function, filling pressure, or biomarker evidence without symptoms. Stage C includes current or prior symptoms with structural disease. Stage D describes advanced symptoms or recurrent instability despite treatment.
Use ejection fraction as a second axis
HFrEF is 40 percent or less, HFmrEF is 41 to 49 percent, HFpEF is at least 50 percent, and HFimpEF requires a prior value of 40 percent or less followed by a value above 40 percent. Document timing, method, loading conditions, and prior nadir.
Do not confuse a ratio with health
Ejection fraction does not directly measure contractility, stroke volume, filling pressure, reserve, or tissue integrity. A small stiff ventricle can eject a preserved fraction while delivering low stroke volume at high pressure. Serial volume, strain, valve, pressure, and etiologic data complete the picture.
Quick check
Submodule
Pump Mechanics and Remodeling
The heart is a coupled pressure, volume, timing, valve, and vascular system. Heart failure appears when compensation can no longer preserve output without excessive pressure or biologic cost.
- Pressure-volume loop
- Preload and compliance
- Afterload and contractility
- Systolic and diastolic dysfunction
Pressure is not volume
Separate from load
Afterload is composite
Prepare the next beat
Read the pressure-volume loop as a story
Filling, isovolumic contraction, ejection, and isovolumic relaxation form the loop. Width represents stroke volume and enclosed area approximates stroke work. End-systolic and diastolic relationships help separate contractile state from chamber compliance and loading.
Separate preload from filling pressure
Preload reflects fiber stretch near end diastole, while measured pressure depends heavily on compliance. A stiff ventricle can reach high pressure with little added volume. Rhythm, filling time, venous tone, pericardial constraint, and atrial contraction modify the relationship.
Treat afterload as a composite
The ventricle ejects against arterial pressure, resistance, impedance, valve obstruction, and wall stress. Contractility is the intrinsic force-generating state, but observed ejection remains load dependent. A cuff pressure alone cannot describe the total load.
Connect mechanics to remodeling
Systolic dysfunction often raises end-systolic volume and promotes dilation. Diastolic dysfunction raises pressure through impaired relaxation or stiffness. Chronic wall stress, ischemia, inflammation, neurohormonal signaling, and altered matrix biology reshape the ventricle and create electrical and valve consequences.
Quick check
Submodule
Neurohormonal Compensation
The failing circulation activates systems designed for short-term survival. Persistent activation retains sodium, raises vascular load, increases oxygen demand, promotes arrhythmia and fibrosis, and accelerates remodeling.
- Sympathetic activation
- RAAS and vasopressin
- Natriuretic peptides
- Remodeling biology
Baroreceptor and kidney signals
Preserve pressure
Chronic toxicity
Progressive substrate
Follow the baroreceptor response
Lower effective perfusion increases sympathetic tone. Heart rate, contractility, venous tone, and vascular resistance support pressure initially. Chronic catecholamine exposure increases oxygen demand, ischemia, receptor dysregulation, calcium stress, arrhythmia, and cell injury.
Follow the kidney response
Renal perfusion, sodium delivery, and sympathetic signaling activate renin, angiotensin II, aldosterone, and vasopressin. Vasoconstriction and sodium and water retention support pressure but worsen congestion, potassium disturbance, fibrosis, and afterload.
Interpret the counter-regulatory peptide system
Wall stress stimulates natriuretic peptides that promote natriuresis, vasodilation, and neurohormonal opposition. BNP and NT-proBNP support diagnosis and prognosis, but age, AF, kidney disease, obesity, acute timing, and therapy change their values.
See remodeling as biology, not geometry alone
Myocyte hypertrophy and death, altered calcium handling, extracellular-matrix turnover, inflammation, fibrosis, chamber dilation or thickening, and secondary valve regurgitation create a new substrate. Symptoms can improve while the structural process still requires surveillance.
Quick check
Submodule
Congestion, Perfusion, and Cardiorenal Physiology
Heart failure harms organs through both inadequate forward flow and excessive backward pressure. Venous congestion is an active mechanism, not merely a visible consequence.
- Pulmonary congestion
- Systemic venous pressure
- Cardiorenal syndrome
- Low output and right-heart failure
Interstitial and alveolar edema
Organ back pressure
Perfusion and oxygen delivery
Interpret the trajectory
Trace pulmonary fluid movement
Elevated left-sided filling pressure raises pulmonary capillary hydrostatic force. Lymphatic reserve delays overt edema, then interstitial and alveolar fluid impair compliance and gas exchange. Examination can be insensitive, so imaging, ultrasound, oxygenation, biomarkers, and context matter.
Treat venous pressure as organ load
High right-sided pressure impairs renal filtration gradient, hepatic drainage, gut absorption, lymphatic return, and abdominal organ function. Jugular pressure, edema, ascites, liver tests, right-ventricular imaging, and the clinical trajectory reveal this burden.
Interpret the kidney in motion
Cardiorenal syndrome includes arterial delivery, venous back pressure, neurohormonal signaling, intra-abdominal pressure, nephrotoxins, and intrinsic kidney disease. A small creatinine rise during effective decongestion is not automatically structural injury, while persistent congestion can be more harmful.
Do not equate pressure with flow
Vasoconstriction can preserve blood pressure despite low cardiac output. Cool extremities, narrow pulse pressure, altered mentation, oliguria, lactate, and hepatic injury signal hypoperfusion. The right ventricle is especially sensitive to pulmonary vascular load, ischemia, rhythm, hypoxia, acidemia, and excessive filling.
Quick check
Submodule
Phenotypes and Diagnostic Reasoning
Heart failure phenotypes organize evidence, but diagnosis remains an iterative process linking symptoms to objective physiology, etiology, precipitant, trajectory, and alternatives.
- HFrEF
- HFpEF and mimics
- Biomarkers and imaging
- Etiology and triggers
Define the cause
Border phenotype
Prove filling-pressure disease
Remission is not cure
Explain reduced ejection fraction
HFrEF can follow ischemia, genetic cardiomyopathy, myocarditis, toxins, tachycardia, valve disease, endocrine or metabolic disease, and chronic loading. Coronary anatomy, scar, family history, exposure, rhythm burden, valves, blood pressure, and reversibility determine the real diagnosis.
Prove preserved-ejection-fraction disease
HFpEF is not preserved ejection fraction plus dyspnea. Supporting filling-pressure or structural and functional evidence is required. Obesity can lower natriuretic peptides, and resting testing can miss exercise-only elevation. Lung disease, anemia, kidney disease, cirrhosis, venous disease, obesity, and deconditioning can mimic it.
Choose the modality that answers the gap
Echocardiography defines chamber, valve, function, strain, and filling clues. Cardiac MRI characterizes scar, inflammation, and infiltration. Coronary testing evaluates ischemia. Exercise echo or invasive hemodynamics can expose latent pressure abnormalities when resting data remain indeterminate.
Find the reason for worsening
Infection, ischemia, arrhythmia, uncontrolled pressure, medication or diet change, kidney injury, anemia, thyroid disease, pulmonary embolism, valve or mechanical complication, and progressive cardiomyopathy are common triggers. Treating fluid without the precipitant invites recurrence.
Quick check
Submodule
Trajectory and Advanced Disease
Heart failure assessment is incomplete without a view of direction. Recurrent admissions, declining function, end-organ dysfunction, therapy intolerance, and escalating support signal a narrowing window for advanced care.
- Longitudinal trajectory
- Advanced heart failure
- Referral timing
- Goals and competing risk
Exclude mimics
Use the right modality
Find reversible disease
Escalate at the right time
Measure direction, not one visit
Daily symptoms fluctuate. Hospitalizations, exercise capacity, renal and hepatic trajectory, diuretic escalation, blood pressure, intolerance of disease therapy, ventricular function, arrhythmia, and device events reveal whether the disease is stable, recovering, or advancing.
Recognize advanced physiology early
Persistent severe symptoms, recurrent congestion, low output, hyponatremia, worsening organ function, escalating diuretic requirements, inability to tolerate therapy, repeated shocks, or dependence on inotropes or temporary support should trigger specialist evaluation.
Refer before options disappear
Transplant, durable mechanical support, complex device or valve intervention, home support, and structured palliative care require time and organ reserve. Waiting for overt shock can allow frailty, kidney injury, liver injury, or malnutrition to close the window.
Integrate goals with physiology
Expected benefit depends on reversibility, competing disease, cognition, frailty, social support, adherence barriers, and what outcomes matter to the patient. Palliative care can accompany disease-directed treatment and is not limited to the final days of life.
Quick check
Module test
Check the connections.
Each attempt draws 10 questions from the complete 104 question bank.
Each attempt draws a fresh set and rearranges the answer choices.
References
Current clinical foundation.
Lecture material was synthesized with the following contemporary guidance. Verify local policy and current guidance before applying clinical information.